https://finance.yahoo.com/news/catalent-linked-regeneron-eye-drug-160359632.html
(Bloomberg) -- Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron Pharmaceuticals Inc., the...
Create an account or login to join the discussion